| Sandoz Pharmaceuticals AG - Estradot 37.5, Transdermales Pflaster |
| 55976 | | 01 | | Estradot 37.5 | | Transdermales Pflaster | | G03CA03 | | Estradiol | | 25.06.2002 | | |
|
| Composition |
| estradiolum 585 µg ut estradiolum hemihydricum, dipropylenglycolum, excipiens ad praeparationem pro 3.75 cm² cum liberatione 37.5 µg/24 h. |
| Packungsbestandteile |
| Transdermal patch | | | | | | | | Active Agent | Dose |
|---|
| Estradiol | 585 µg correspond Estradiol Hemihydrate |
| | BAG: Active Agent | Dose |
|---|
| Estradiol | 0.585 mg |
| | | | Inactive agents |
|---|
| Dipropylenglycol |
| |
|
|
